- Home
- CVM vs FCO Comparison
CVM vs FCO Comparison
Compare CVM & FCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CVM | FCO |
|---|---|---|
| Founded | 1983 | 1991 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.3M | 39.4M |
| IPO Year | 1987 | N/A |
Fundamental Metrics
Financial Performance| Metric | CVM | FCO |
|---|---|---|
| Price | $5.29 | $3.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 80.6K | ★ 100.1K |
| Earning Date | 02-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 14.96% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.30 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.98 | $4.73 |
| 52 Week High | $20.41 | $6.63 |
Technical Indicators
Market Signals| Indicator | CVM | FCO |
|---|---|---|
| Relative Strength Index (RSI) | 44.66 | 68.16 |
| Support Level | $4.90 | $3.11 |
| Resistance Level | $6.75 | $3.16 |
| Average True Range (ATR) | 0.64 | 0.08 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 21.62 | 77.78 |
Price Performance
Historical ComparisonAbout CVM Cel-Sci Corporation
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.